Within its last year performance, SLRN fell by -35.97%, with highs and lows ranging from $9.64 to $3.36, whereas the simple moving average jumped by 5.53% in the last 200 days.
On August 14, 2024, H.C. Wainwright Downgraded Acelyrin Inc (NASDAQ: SLRN) to Neutral. A report published by Wells Fargo on July 08, 2024, Upgraded its rating to ‘Overweight’ for SLRN. Wells Fargo also rated SLRN shares as ‘Equal Weight’, setting a target price of $11 on the company’s shares in an initiating report dated December 13, 2023. Citigroup Initiated an Neutral rating on December 08, 2023, and assigned a price target of $8. Morgan Stanley September 13, 2023d its ‘Overweight’ rating to ‘Equal-Weight’ for SLRN, as published in its report on September 13, 2023. H.C. Wainwright’s report from September 05, 2023 suggests a price prediction of $44 for SLRN shares, giving the stock a ‘Buy’ rating. TD Cowen also rated the stock as ‘Outperform’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Acelyrin Inc (SLRN)
Acelyrin Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -43.79% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 7.86, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and SLRN has an average volume of 914.60K. On a monthly basis, the volatility of the stock is set at 7.06%, whereas on a weekly basis, it is put at 7.44%, with a gain of 1.69% over the past seven days. Furthermore, long-term investors anticipate a median target price of $11.80, showing growth from the present price of $6.00, which can serve as yet another indication of whether SLRN is worth investing in or should be passed over.
How Do You Analyze Acelyrin Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 25.60%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 77.75% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
SLRN shares are owned by institutional investors to the tune of 77.75% at present.
